Published February, 2014
By Holger Schmid-Schonbein, Colin G. Caro, Charles Baquey, Florentina Mosora, Egon Krause and Holger Schmid-Schoenbein
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Nato Science Series A:
Rating:
Availability: Available

Proceedings of a NATO ARW held in Cargese, France, October 9-13, 1989

---

Published February, 2014
By John Bartholomew and Alan Lichtin
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP).The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments.

---

Published January, 2014
By David S. Allan and Dirk Strunk
Publisher: Springer (Humana Press Inc.)
Series: Stem Cell Biology and Regenerative Medicine
Rating:
Availability: Available

Some of these cell types and various blood-derived cell lineages are involved in the repair of various types of tissue damage that span the spectrum of medical disorders.

---

Published January, 2014
By Domenico Ribatti
Publisher: Springer
Rating:
Availability: Available

Angiogenesis and Anti-Angiogenesis in Hematological Malignancies

---

Published January, 2014
By Volker Diehl
Publisher: Elsevier (Elsevier - Health Sciences Division)
Series: The Clinics: Internal Medicine
Rating:
Availability: Available

---

Published January, 2014
By Martin H. Bluth
Publisher: Elsevier (Elsevier - Health Sciences Division)
Series: The Clinics: Internal Medicine
Rating:
Availability: Available

---

Published January, 2014
By Peter A. Jones and Michael Lubbert
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically.

---

Published January, 2014
By Hae Won Kim and A. Gerson Greenburg
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions.

---

Published December, 2013
By Edward P. Gelmann, Charles L. Sawyers, Frank J. Rauscher III, Frank J. Rauscher and Edward P. Gelman
Publisher: Cambridge University Press
Rating:
Availability: Available

The genomic era has greatly facilitated the understanding of the molecular changes that underlie malignant transformation. This timely foundation for understanding the origins of molecular oncology reviews available technologies for cancer analysis, summaries of key oncogenic pathways for a wide range of human malignancies, and pharmacologic therapies in development.

---

Published December, 2013
By Gregory H. Reaman, Franklin O. Smith, Judy M. Racadio, SHANAH COLE and Franklin Smith
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Pediatric Oncology
Rating:
Availability: Available

After an introductory chapter describing the history of pediatric blood and marrow transplantation, subsequent chapters discuss pediatric-specific aspects of transplantation, including stem cell sources suitable for transplantation, preparative regimens, graft-versus-host disease, complications related to transplantation, and late effects.

---